These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38798821)

  • 1. Prevalence of subclinical pulmonary tuberculosis and its association with HIV in household contacts of index tuberculosis patients in two South African provinces: a secondary, cross-sectional analysis of a cluster-randomised trial.
    Carter N; Webb EL; Lebina L; Motsomi K; Bosch Z; Martinson NA; MacPherson P
    BMC Glob Public Health; 2023; 1(1):21. PubMed ID: 38798821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS).
    Klinkenberg E; Floyd S; Shanaube K; Mureithi L; Gachie T; de Haas P; Kosloff B; Dodd PJ; Ruperez M; Wapamesa C; Burnett JM; Kalisvaart N; Kasese N; Vermaak R; Schaap A; Fidler S; Hayes R; Ayles H;
    PLoS Med; 2023 Sep; 20(9):e1004278. PubMed ID: 37682971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors for latent tuberculosis infection among household contacts of index cases in two South African provinces: Analysis of baseline data from a cluster-randomised trial.
    MacPherson P; Lebina L; Motsomi K; Bosch Z; Milovanovic M; Ratsela A; Lala S; Variava E; Golub JE; Webb EL; Martinson NA
    PLoS One; 2020; 15(3):e0230376. PubMed ID: 32182274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.
    Shapiro AE; Ross JM; Yao M; Schiller I; Kohli M; Dendukuri N; Steingart KR; Horne DJ
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013694. PubMed ID: 33755189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening tests for active pulmonary tuberculosis in children.
    Vonasek B; Ness T; Takwoingi Y; Kay AW; van Wyk SS; Ouellette L; Marais BJ; Steingart KR; Mandalakas AM
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013693. PubMed ID: 34180536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of GeneXpert MTB/RIF for Diagnosing Tuberculosis Among Symptomatic Household Contacts of Index Patients in South Africa.
    Velen K; Podewils LJ; Shah NS; Lewis JJ; Dinake T; Churchyard GJ; Reichler M; Charalambous S
    Open Forum Infect Dis; 2021 Apr; 8(4):ofab025. PubMed ID: 33884274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening intervention.
    Chatla C; Jaju J; Achanta S; Samyuktha R; Chakramahanti S; Purad C; Chepuri R; Nair SA; Parmar M
    Indian J Tuberc; 2018 Jul; 65(3):218-224. PubMed ID: 29933863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia.
    Elliott AM; Hayes RJ; Halwiindi B; Luo N; Tembo G; Pobee JO; Nunn PP; McAdam KP
    AIDS; 1993 Jul; 7(7):981-7. PubMed ID: 8357557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.
    Kay AW; González Fernández L; Takwoingi Y; Eisenhut M; Detjen AK; Steingart KR; Mandalakas AM
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013359. PubMed ID: 32853411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Policy and programmatic directions for the Lesotho tuberculosis programme: Findings of the national tuberculosis prevalence survey, 2019.
    Matji R; Maama L; Roscigno G; Lerotholi M; Agonafir M; Sekibira R; Law I; Tadolini M; Kak N
    PLoS One; 2023; 18(3):e0273245. PubMed ID: 36893175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children.
    Kay AW; Ness T; Verkuijl SE; Viney K; Brands A; Masini T; González Fernández L; Eisenhut M; Detjen AK; Mandalakas AM; Steingart KR; Takwoingi Y
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013359. PubMed ID: 36065889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the contribution of subclinical tuberculosis disease to transmission: An individual patient data analysis from prevalence surveys.
    Emery JC; Dodd PJ; Banu S; Frascella B; Garden FL; Horton KC; Hossain S; Law I; van Leth F; Marks GB; Nguyen HB; Nguyen HV; Onozaki I; Quelapio MID; Richards AS; Shaikh N; Tiemersma EW; White RG; Zaman K; Cobelens F; Houben RMGJ
    Elife; 2023 Dec; 12():. PubMed ID: 38109277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
    Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
    BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Missed Opportunities for TB Investigation in Primary Care Clinics in South Africa: Experience from the XTEND Trial.
    Chihota VN; Ginindza S; McCarthy K; Grant AD; Churchyard G; Fielding K
    PLoS One; 2015; 10(9):e0138149. PubMed ID: 26383102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Household Contact Tracing With Intensified Tuberculosis and Human Immunodeficiency Virus Screening in South Africa: A Cluster-Randomized Trial.
    Martinson NA; Lebina L; Webb EL; Ratsela A; Varavia E; Kinghorn A; Lala SG; Golub JE; Bosch Z; Motsomi KP; MacPherson P
    Clin Infect Dis; 2022 Sep; 75(5):849-856. PubMed ID: 34950944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of subclinical tuberculosis in household contacts using exposure scores and contact investigations.
    Bekken GK; Ritz C; Selvam S; Jesuraj N; Hesseling AC; Doherty TM; Grewal HMS; Vaz M; Jenum S
    BMC Infect Dis; 2020 Jan; 20(1):96. PubMed ID: 32005136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of WHO's pragmatic screening algorithm for child contacts of tuberculosis cases in resource-constrained settings: a prospective cohort study in Uganda.
    Martinez L; Shen Y; Handel A; Chakraburty S; Stein CM; Malone LL; Boom WH; Quinn FD; Joloba ML; Whalen CC; Zalwango S
    Lancet Respir Med; 2018 Apr; 6(4):276-286. PubMed ID: 29273539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.